Nicotine is primarily used recreationally as a stimulant for its mood-altering and pleasure-inducing effects, commonly consumed through tobacco smoking, vaping, smokeless tobacco, and nicotine pouches. It is also widely used medically in Nicotine Replacement Therapy (NRT) products—such as patches, gum, lozenges, and nasal sprays—to help individuals quit smoking by managing withdrawal symptoms and cravings without the harmful chemicals found in tobacco smoke. Historically and in agriculture, nicotine serves as an insecticide, acting on nicotinic acetylcholine receptors to control pests; however, its use in consumer products has been banned in the US and EU due to toxicity, though synthetic derivatives like neonicotinoids remain in widespread agricultural use. Additionally, nicotine is investigated for potential cognitive enhancement and therapeutic applications in neurodegenerative conditions like Parkinson’s and Alzheimer’s disease, leveraging its ability to improve attention, memory, and focus through receptor activation.
Medical Use: Nicotine Replacement Therapy (NRT)
Nicotine is medically used in Nicotine Replacement Therapy (NRT) to help individuals quit smoking by reducing withdrawal symptoms and cravings. NRT delivers controlled doses of nicotine without the harmful toxins found in tobacco smoke, such as tar and carbon monoxide. It is available in various forms—including patches, gum, lozenges, nasal sprays, and inhalers—and is FDA-approved. Studies show that NRT can increase the success rate of quitting smoking by 50% to 70%, with combination therapy (e.g., patch plus gum) being more effective than single products. NRT is considered safe, even for people with stable cardiovascular disease, as it does not increase coagulability or expose users to carbon monoxide.
Recreational Use: Stimulant and Mood Modulator Recreationally, nicotine is primarily consumed through smoking, vaping, chewing tobacco, or nicotine pouches for its stimulant and mood-altering effects. It enhances alertness, concentration, and fine motor skills while also producing calming or anxiolytic effects depending on the pattern of use. These dual effects are due to how users inhale: deeper puffs increase blood nicotine levels and promote relaxation, while shorter, frequent puffs maintain alertness. Nicotine activates nicotinic acetylcholine receptors in the brain, triggering dopamine release in the reward system, which underlies its high addictive potential.
Agricultural Use: Insecticide and Neonicotinoids
Historically, nicotine was widely used as a natural insecticide due to its neurotoxic effects on insects. It acts as a contact poison, disrupting the nervous system by overstimulating nicotinic acetylcholine receptors, leading to paralysis and death in pests like aphids, whiteflies, and beetles. However, due to its high toxicity to humans and environmental concerns, nicotine-based pesticides have been banned commercially in the U.S. and EU. Instead, synthetic derivatives called neonicotinoids (e.g., imidacloprid) are now widely used. These are systemic insecticides absorbed by plants, offering longer protection but raising concerns about impacts on pollinators like bees.
Cognitive and Therapeutic Potential
Nicotine has shown potential cognitive-enhancing effects, including improvements in attention, working memory, and fine motor control. A 2010 meta-analysis of 41 studies found significant positive effects of nicotine on these functions. Research suggests stimulation of the α4β2 nicotinic receptor is responsible for these benefits, making nicotine a subject of investigation for treating neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Tourette’s syndrome, as well as inflammatory conditions like ulcerative colitis. While not directly carcinogenic, nicotine may promote tumor growth by inhibiting apoptosis and stimulating angiogenesis, though this risk is far lower than that posed by tobacco smoke.
Medical and Therapeutic Uses of Nicotine
Nicotine is being actively studied for its therapeutic potential in various neurological and inflammatory conditions. Clinical research shows nicotine may improve cognitive function in disorders like Alzheimer’s disease, where it reduces β-amyloid accumulation in transgenic mice, and Parkinson’s disease, where it provides neuroprotection to dopamine neurons. In attention deficit hyperactivity disorder (ADHD), a 7 mg nicotine patch improved stop-signal reaction time, while in major depressive disorder, nicotine lozenges normalized cortico-striatal connectivity. It also shows anti-inflammatory effects in rheumatoid arthritis, ulcerative colitis, and sepsis, largely mediated through the α7 nicotinic acetylcholine receptor (α7nAChR) and downstream pathways like NF-κB and JAK2/STAT3.
Cognitive Enhancement and Mental Performance
Nicotine enhances attention, working memory, and psychomotor speed, particularly in individuals with cognitive impairments. A 6-month clinical trial found transdermal nicotine (15 mg/day) significantly improved attention (measured by Connors CPT, effect size 0.78), long-term memory, and processing speed in non-smokers with mild cognitive impairment (MCI). Nicotine nasal spray has also shown dose-related improvements in sustained attention and computational processing in smokers, with women showing greater sensitivity to its subjective effects. These benefits are attributed to nicotine’s stimulation of α4β2 and α7 nicotinic receptors, enhancing neurotransmitter release (dopamine, norepinephrine).
Agricultural Use and Environmental Impact of Neonicotinoids
While nicotine itself is no longer used as an insecticide due to high human toxicity, its synthetic analogs—neonicotinoids (e.g., imidacloprid)—are widely used in agriculture. These systemic pesticides are absorbed by plants but only about 5% is taken up by crops; the rest disperses into soil, water, and air. They are highly water-soluble and persistent, leading to widespread contamination of groundwater, streams, and wetlands. Neonicotinoids pose serious risks to pollinators: they impair honeybee navigation, reduce bumblebee colony growth, and decrease queen production. The European Food Safety Authority (EFSA) recommended a moratorium on three major neonicotinoids due to bee risks, implemented in 2013. The U.S. EPA has also found over 200 endangered species are at risk of extinction due to these chemicals, which harm aquatic invertebrates and migratory birds.
Neonicotinoid class of insecticides
Medical and Therapeutic Uses of Nicotine
Nicotine is under active investigation for treating neurodegenerative and inflammatory diseases. Clinical trials are exploring its use in pulmonary sarcoidosis, depression, and tobacco use disorder, with delivery methods including patches, lozenges, and nasal sprays. In Alzheimer’s disease, nicotine reduces β-amyloid accumulation in animal models. In Parkinson’s disease, it protects dopamine neurons and may reduce L-dopa-induced dyskinesias. For ADHD, a 7 mg patch improved attention, while in major depressive disorder, nicotine lozenges normalized cortico-striatal connectivity. It also shows anti-inflammatory effects in rheumatoid arthritis, osteoarthritis, ulcerative colitis, and sepsis, primarily through the α7 nicotinic acetylcholine receptor (α7nAChR) pathway.
Cognitive Enhancement and Neurocognitive Effects
Nicotine enhances attention, working memory, processing speed, and fine motor skills. A 6-month trial showed transdermal nicotine (15 mg/day) significantly improved attention (effect size 0.78) and long-term memory in non-smokers with mild cognitive impairment (MCI). Nicotine nasal spray improves sustained attention and computational processing in a dose-dependent manner, particularly in non-deprived smokers. Functional MRI studies show nicotine reduces activity in the default-mode network (linked to mind-wandering) and increases activity in executive control networks, enhancing focus. Women appear more sensitive to nicotine’s subjective and cognitive effects than men.
Environmental and Health Impact of Neonicotinoids
While nicotine itself is no longer used as a pesticide, neonicotinoids—its synthetic derivatives—are among the most widely used insecticides globally. They are systemic, water-soluble, and persistent, leading to widespread contamination of soil, groundwater, rivers, and crops. Only about 5% is absorbed by plants; the rest leaches into the environment. They are highly toxic to pollinators: field studies show reduced wild bee populations, impaired honeybee navigation, and suppressed bumblebee colony growth. Neonicotinoids also harm aquatic invertebrates, earthworms, and insectivorous birds by reducing food availability. The European Union has restricted several due to bee risks, and the U.S. EPA has found over 200 endangered species are at risk. Emerging evidence also links human exposure to neurodevelopmental delays, endocrine disruption, and reproductive issues.
Medical and Therapeutic Uses of Nicotine
Nicotine is being studied for its therapeutic potential in various neurological and inflammatory diseases. Clinical and preclinical studies show benefits in Alzheimer’s disease, where it reduces β-amyloid accumulation via α7nAChR and MAPK/NF-κB pathways. In Parkinson’s disease, nicotine protects dopamine neurons and may reduce L-dopa-induced dyskinesias. It improves ADHD symptoms, such as stop-signal reaction time, and normalizes cortico-striatal connectivity in major depressive disorder. Nicotine also exhibits anti-inflammatory effects in rheumatoid arthritis, osteoarthritis, ulcerative colitis, and sepsis, primarily through the α7nAChR and JAK2/STAT3 signaling.
EXPANDED Cognitive Enhancement Mechanisms
Nicotine enhances attention, memory, and executive function by activating nicotinic acetylcholine receptors (nAChRs), particularly α4β2 and α7 subtypes. It improves neuronal communication by stimulating PDE-5, TRβ, and CaMKII, and enhances long-term potentiation (LTP) via the PI3K/AKT pathway, which is critical in Alzheimer’s. Nicotine also inhibits HDACs and SIRT6, reducing neural apoptosis in Parkinson’s. In healthy individuals, it counteracts memory deficits from sleep deprivation by enhancing CaMKII phosphorylation. Functional MRI studies show nicotine reduces default-mode network activity and increases executive control network engagement.
Neonicotinoids: Environmental and Human Health Risks
While nicotine itself is not used as a pesticide, neonicotinoids (e.g., imidacloprid) are widely used systemic insecticides. They are highly water-soluble and persistent, contaminating soil, groundwater, and aquatic ecosystems. Exposure harms pollinators, impairing bee navigation and colony growth. Emerging evidence shows human health risks: the metabolite desnitro-imidacloprid binds strongly to human α4β2 and α7 nAChRs, causing neurotoxicity, memory impairment, and headaches. Prenatal exposure is linked to congenital heart defects and cognitive impairment. Neonicotinoids also show reproductive toxicity, reducing sperm count and motility in rodents. Regulatory actions are increasing, with bills proposed in Minnesota and other regions to restrict their use.
Q&A SECTION:
What are the side effects of nicotine replacement therapy?
Common Side Effects of Nicotine Replacement Therapy (NRT)
The most frequently reported side effects of Nicotine Replacement Therapy (NRT) are generally mild and vary by delivery method. According to a meta-analysis of 120 studies involving over 177,000 individuals:
• Skin irritation (19.5% of patch users) is the most common side effect, including redness, itching, and rash at the application site.
• Headache affects around 9.7% of users.
• Nausea or vomiting occurs in approximately 8.5% of individuals.
• Insomnia is reported by 11.4% of users, particularly with 24-hour nicotine patches.
• Dizziness affects about 7.3% of users.
• Mouth and throat soreness is common with gum, lozenges, and inhalers (5.4%).
• Hiccoughs and coughing are frequently associated with oral forms of NRT.
Serious Adverse Events and Safety
Serious adverse events are rare. Clinical trials show no significant increase in depression or anxiety with NRT use. However, there is a statistically significant increased risk of:
• Heart palpitations and chest pains (OR 2.06).
• Gastrointestinal complaints (OR 1.54).
Observational studies have documented rare cases of stroke, myocardial infarction, urticaria, and angioedema. A large study found 0.2% of users reported self-harm, but causality with NRT remains unclear. Overall, NRT is considered safe for most people, including those with stable cardiovascular disease.
Is it safe?
Long-term use of Nicotine Replacement Therapy (NRT) is considered safe and significantly less harmful than continued smoking. According to the UK’s National Institute for Health and Care Excellence (NICE), studies with up to 5-year follow-up show that “pure” nicotine in NRT does not pose a significant health risk. The U.S. Surgeon General also found inadequate evidence to determine a causal link between nicotine and cancer. That’s an interesting statement from the Head Doc in the U.S.A.
Animal studies and limited human data, including the Lung Health Study, provide reassurance that NRT does not promote lung cancer or other major diseases. While laboratory studies suggest nicotine may have carcinogenic potential, real-world evidence indicates any risk is far lower than that of smoking. Long-term NRT users who have quit smoking fully replace cigarette-derived nicotine without increased overall nicotine intake. NRT does not increase cardiovascular risk, cause platelet aggregation, or lead to significant changes in heart rate or blood pressure. It is a safe and effective method for harm reduction, especially for high-risk individuals preventing relapse. Long-term use of Nicotine Replacement Therapy (NRT) is considered safe and significantly less harmful than continued smoking. Studies with up to 5 years of follow-up, including the Lung Health Study, show no significant increase in cancer, cardiovascular disease, or mortality among NRT users. The U.S. Surgeon General and UK health authorities have found inadequate evidence linking NRT to cancer, and animal studies suggest it does not promote lung cancer. While NRT may cause mild side effects like skin irritation (patches), mouth soreness (gum/lozenges), or insomnia, serious adverse events are rare. A 2017 cohort study noted a slightly higher risk of ischemic heart disease and cerebrovascular events after 52 weeks of NRT use, but this may reflect underlying risk factors rather than direct causation. Overall, NRT does not increase heart attack risk, induce platelet aggregation, or cause major changes in heart rate or blood pressure. For individuals at high risk of relapse, long-term NRT is a safe and effective harm reduction strategy, offering substantial health benefits compared to continued smoking.
So, as of the past four years it has also been revealed that those who had nicotine, cotinine, and other metabolites on board, they were less susceptible to COVID. I find that to be fascinating. Weren’t we always told “nicotine is bad”? I was as a kid who grew up in the late 1960’s-1970’s. Side note: in the 1940-1950’s medical doctors used to prescribe cigarettes and smoking. Hmmm… I am not advocating that you start smoking cigarettes, however, I really do not see an issue with the use of nicotine pouches at this point. Continue to do your own research, and remember, your health is your responsibility, first, not someone’s in a white lab coat. Take care, and I hope you have enjoyed this for educational purposes only article!
Support Independent Local Journalism — High Country Advocate was created as a real alternative to regional media that too often silences dissenting voices while taking sides in the political struggle. Producing in-depth, unflinching reporting like this series and others is expensive: servers, editing, research time, and legal review all add up quickly. If these articles have informed you or given you new perspective, please consider supporting HCA with a paid subscription — every subscriber helps keep this reporting strong and independent. 